MarketInOut Stock Screener Log In | Sign Up
 

Neuraxis Inc

NYSE • Healthcare • Biotechnology • Quote as of 10/23/2026
Neuraxis Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization95.19 mln
Float8.55 mln
Earnings Date11/17/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-1.56
Likely manipulated

Relative Strength

92 / 100
Top performer

Debt / Equity

0.04
Debt-free

Pre-Tax Margin

-144%
Severely loss-making

ROE

-171
Deeply negative

Business Description

NeurAxis Inc. is a U.S. medical device company founded in 2011 and based in Carmel, Indiana, that creates treatments using electrical nerve stimulation to help both children and adults manage painful long-term conditions. Its flagship product, IB-Stim, is cleared for use in patients as young as eight years old to relieve stomach pain linked to irritable bowel syndrome, functional dyspepsia, and related nausea. The company also offers a diagnostic device that helps doctors identify problems with bowel function, and it distributes its products directly to hospitals and clinics across the country.

Key Fundamentals

EPS-0.78
ROE-171
RPS0.49
ROIC-331
ROA-101
Interest Cover-148
EBITDA, mln-7.47
EV / EBITDA-10.98
EV / EBIT-10.87
Revenue, mln5.32
EV / Revenue15.43

Quote Details

Last 7.40
Change -0.2 (-2.63%)
Open 7.57
Volume 75,206
Turnover 556,524
Average Volume 144,974

Financial Ratios

Pre-Tax Profit Margin-144
Leverage Ratio1.48
Current Ratio3.04
Price / Book13.66
Price / Tangible Book14.18
Debt / Equity0.04
Price / Sales15.41

Financial Strength

Altman Z-Score6.97
Piotroski F-Score 5 / 9
Beneish M-Score-1.56
Short Ratio2.45
Short % of Float3.79

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.9% 19 / 100   
1 Month -4.52% 42 / 100   
2 Months 7.87% 85 / 100   
6 Months -5.85% 40 / 100   
1 Year 95.25% 97 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog